$GILD Recent News Gilead Sciences shares slide 1.7%

New Post Public Reply Private Reply Replies (0) Message Board

Nov 19, 2014 at 11:09 AM

$GILD Recent News

Gilead Sciences shares slide 1.7% 9:35 a.m. Today - Sue Chang
Are consumers getting gouged on health care? 12:58 p.m. Nov. 18, 2014 - Russ Britt
The double-edged sword of growth-stock speculation 2:29 p.m. Nov. 14, 2014 - The Trading Deck
10 S&P 500 companies with the fastest revenue growth 8:28 a.m. Nov. 11, 2014 - Philip van Doorn
Merck, Dendreon miss out on health-care rally 12:39 p.m. Nov. 10, 2014 - Russ Britt
Gilead Sciences rises 2% to top S&P 500 gainers 9:31 a.m. Nov. 10, 2014 - Sue Chang
Visa shares rise after hours on earnings beat 6:50 p.m. Oct. 29, 2014 - Sue Chang
Warren Buffett best wear his trunks as Fed preps to end (pause) the printing 8:34 a.m. Oct. 29, 2014 - Shawn Langlois
Facebook, Gilead shares fall after hours 6:14 p.m. Oct. 28, 2014 - Sue Chang
Updates, advisories and surprises 5:01 p.m. Oct. 28, 2014 - MarketWatch
Sales of Gilead's pricey hepatitis C drug slow 4:26 p.m. Oct. 28, 2014 - MarketWatch.com
Gilead Sciences' stock pulls back from record high close after earnings miss 4:14 p.m. Oct. 28, 2014 - Tomi Kilgore
Gilead's stock drops 3.6% in after-hours trade after Q3 results 4:09 p.m. Oct. 28, 2014 - Tomi Kilgore
Gilead revises 2014 product sales outlook to $22 bln-$23 bln from $21 bln-$23 bln 4:08 p.m. Oct. 28, 2014 - Tomi Kilgore
Gilead Q3 Sovaldi sales $2.8 bln vs. $3.48 bln in Q2 4:07 p.m. Oct. 28, 2014 - Tomi Kilgore
Gilead Q3 sales top FactSet consensus estimate of $5.99 bln 4:07 p.m. Oct. 28, 2014 - Tomi Kilgore
Gilead Q3 sales $6.04 bln vs. $2.78 bln a year ago 4:07 p.m. Oct. 28, 2014 - Tomi Kilgore
Gilead Q3 net EPS $1.67 vs. 47 cents a year ago 4:06 p.m. Oct. 28, 2014 - Tomi Kilgore
Gilead Sciences Q3 adj. EPS $1.84 vs. FactSet consensus $1.92 4:06 p.m. Oct. 28, 2014 - Tomi Kilgore
Two biotech leaders to watch 2:12 p.m. Oct. 28, 2014 - The Trading Deck

Stock Market News for November 19, 2014 - Market News 59 min ago - Zacks.com
Stock Market Today: Oil Slump Fuels S&P 500 to Fresh Record High 4:09 p.m. Nov. 18, 2014 - TheStreet.com
Gilead's Value Without Its Hep C Franchise 4:07 p.m. Nov. 18, 2014 - Seeking Alpha
Stock Market Today: S&P 500 Notches New High as Oil Prices Slip and Slide 2:23 p.m. Nov. 18, 2014 - TheStreet.com
Stock Movers: Why 4 Big Drug Stocks Are Rising Today 1:38 p.m. Nov. 18, 2014 - Investors Business Daily
Gilead Sciences (GILD) Stock Rises After European Commission Market Authorization for Harvoni 10:48 a.m. Nov. 18, 2014 - TheStreet.com
Buy Gilead Sciences Now At A Historic Low Valuation 8:52 a.m. Nov. 18, 2014 - Seeking Alpha
Dispelling Some Of The Myths Surrounding Gilead Sciences. 8:22 a.m. Nov. 18, 2014 - Seeking Alpha
Trade of the Day: Gilead Sciences (GILD) 3:16 a.m. Nov. 18, 2014 - InvestorPlace.com
Trade of the Day: Gilead Sciences Stock on Sale 7:56 p.m. Nov. 17, 2014 - InvestorPlace.com
Incyte Building Blockbuster Drug One Disease At A Time 2:58 p.m. Nov. 17, 2014 - Investors Business Daily
Jim Cramer Answers Twitter (TWTR) Questions on Gold, Gilead and More 2:53 p.m. Nov. 17, 2014 - TheStreet.com
Gilead Has Been Rocked After Earnings, But I'm Looking To Buy! 12:35 p.m. Nov. 17, 2014 - Seeking Alpha
AZN, PFE And GILD, 3 Drugs Stocks Pushing The Industry Lower 12:04 p.m. Nov. 17, 2014 - TheStreet.com
3 Stocks Reiterated As A Buy: GE, GILD, PG 11:14 a.m. Nov. 17, 2014 - TheStreet.com
Stock Market News for November 17, 2014 - Market News 10:10 a.m. Nov. 17, 2014 - Zacks.com
Weekly CFO Sells Highlight: Tableau Software Inc, Gilead Sciences Inc, Facebook Inc. 9:36 p.m. Nov. 16, 2014 - GuruFocus.com
Insider Selling Surges as Markets Hit Record High 8:25 a.m. Nov. 15, 2014 - 247WallSt.com
'Fast Money' Recap: Was Friday the Start of a Bull Rally in Gold? 5:00 a.m. Nov. 15, 2014 - TheStreet.com
Biotech Stocks Hit: Stock Market To See New Leaders? 5:22 p.m. Nov. 14, 2014 - Investors Business Daily

European Commission Grants Marketing Authorization for Gilead’s Harvoni®▼ (Ledipasvir/Sofosbuvir), the First Single Tablet Regimen to Treat the Majority of Chronic Hepatitis C Patients With Genotype 1 and 4 10:07 a.m. Nov. 18, 2014 - BusinessWire - BZX
Earnings Forecast Buzz for Baker Hughes, Halliburton, Apple, Gilead Sciences, Kinder Morgan, and Alibaba 8:45 a.m. Nov. 18, 2014 - PR Newswire - PRF
Equity Coverage on Biotech Industry - Gilead Sciences, MannKind, ARIAD Pharma, iBio Inc., and Celgene 9:10 a.m. Nov. 14, 2014 - PR Newswire - PRF
Reveal Earnings Forecast for BlackBerry, Twitter, Alibaba, Sirius XM, Gilead Sciences, and JD.Com 8:45 a.m. Nov. 14, 2014 - PR Newswire - PRF
Gilead Prices $4 Billion of Senior Unsecured Notes 5:59 p.m. Nov. 12, 2014 - BusinessWire - BZX
Earnings Forecast Recap for Alibaba, Apple, Zynga, Gilead Sciences, Dendreon, and Juniper 8:45 a.m. Nov. 12, 2014 - PR Newswire - PRF
Gilead Announces Phase 2 Data for Investigational All-Oral Regimen of Sofosbuvir Plus GS-5816 for the Treatment of Chronic Hepatitis C 8:02 a.m. Nov. 11, 2014 - BusinessWire - BZX
Gilead Announces Harvoni Study Results in Chronic Hepatitis C Patients with Advanced Liver Disease and Those Who Failed Prior Treatment 8:02 a.m. Nov. 11, 2014 - BusinessWire - BZX
Earnings Forecast Buzz for Alibaba, Genworth Financial, Gilead Sciences, Zynga, Abercrombie & Fitch, and Plug Power 8:45 a.m. Nov. 10, 2014 - PR Newswire - PRF
Medifocus to Be Broadcast on BNN and Fox Business News on November 8th and 9th, 2014 10:56 a.m. Nov. 7, 2014 - Marketwired
Linkage Biosciences Adds to Board Leadership 8:02 a.m. Nov. 7, 2014 - Marketwired
Critical Alerts For Delta Airlines, ConocoPhillips, Qualcomm, Kinder Morgan and Gilead Sciences Released By InvestorsObserver 9:31 a.m. Nov. 6, 2014 - PR Newswire - PRF
Gilead Submits New Drug Application to U.S. Food and Drug Administration for Tenofovir Alafenamide (TAF)-Based Single Tablet Regimen for HIV 8:32 a.m. Nov. 6, 2014 - BusinessWire - BZX
Earnings Forecast Buzz for Alibaba, GT Advanced Technologies, GoPro, Plug Power, Gilead Sciences, and American Realty Capital Properties 8:45 a.m. Nov. 4, 2014 - PR Newswire - PRF
Life-Science New Build Report: 200 New North American Sites in Planning Represent Potential $15 Billion Investment, an Industrial Info News Alert 6:16 a.m. Nov. 4, 2014 - Marketwired
Gilead Sciences Once Again Tops the List of California's Most Honored Companies in Institutional Investor's All-America Executive Team Ranking 6:15 a.m. Nov. 4, 2014 - Marketwired
Earnings Forecast Buzz for American Realty Capital Properties, Alibaba, Petroleo Brasileiro Petrobras SA, Gilead Sciences, RF Micro Devices, and GoPro 8:45 a.m. Oct. 30, 2014 - PR Newswire - PRF
Compliance Notice, Dividend Announcements, New Share Repurchase Program, and Financial Results - Research Reports on Gilead, Pfizer, AbbVie, Edwards and Lilly 8:35 a.m. Oct. 29, 2014 - PR Newswire - PRF
Gilead Sciences Announces Third Quarter 2014 Financial Results 4:09 p.m. Oct. 28, 2014 - BusinessWire - BZX
Earnings Forecast Research for DryShips, GoPro, Gilead Sciences, MannKind, GT Advanced Technologies, and Amazon 8:45 a.m. Oct. 27, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Advocacy for Hiring Disabled Kidney Patients Gains Steam

Making Jobs Accessible for Kidney Patients Well, things are stirring up on Capitol Hill, and it's high time, if you ask me. The American Association of Kidney Patients (AAKP) is rallying hard for a bipartisan bill that could change the landscape for folks grappling with kidney diseases and disabilities. You’ve got Reps Pete Sessions and Steny Hoyer pushing this American...

Hansa's Idefirix Shows Promise for Kidney Transplants

Compelling Progress from Hansa Biopharma Y'know, navigating through the biotech jungle isn't for the faint-hearted. Hansa Biopharma's recent results with Idefirix could just be the beacon of hope for patients struggling on transplant lists. Announced at the ASN Kidney Week—a name that's got weight, by the way—these findings aren't just filling space. They're promising...

Roadrunner's Bold Move: New LTL Service and Rate Hike

When you shake up the status quo in logistics, you better be ready for the ride. Roadrunner Freight is doing just that with the launch of its first-ever outbound Canada-to-U.S. LTL service. They're shaking up a market that's been bogged down with inefficiencies for far too long. This isn't just another lane to add to a map; it's a new passage for Canadian goods, paving a...

Venture Dock Fosters Global Startup Ecosystems

Venture Dock Connects the Global Startup Dots When it comes down to bridging the gap between promising innovation and commercial success, you'd be hard-pressed to find a better player than Venture Dock. In a world filled with buzzwords and fluff, these guys are socketed deep in the guts of genuine startup development — and they're making waves with their recent...

Full-Life's FL-020 Shows Promise for Prostate Cancer

Breaking New Ground in Prostate Cancer Treatment You know, it’s not every day you stumble across news in the medical field that perks up the ears of investors, but let me tell ya, Full-Life Technologies' latest data drop has certainly caught my attention. If there’s even a smidge of truth in these findings, we might have a game-changer on our hands in the realm of...

MATIC S68 Wheels: A Bold Step for Superteam

Premium Racing Takes a New Spin Scratch the surface of a tire-obsessed market, and you'll find Superteam Wheels making a calculated leap. Their new premium sub-brand, MATIC, isn't just fluff—it shows a serious attempt to impress those who’d rather cut corners on a track than a spreadsheet. Introducing the MATIC S68—buttery smooth, pitch-perfect, and undeniably...

Boots Group Wraps Up Consent Solicitation for Notes

Consent Solicitation's Critical Role in Acquisition No time for dawdling—Boots Group's gathered up their consent cards for hefty senior secured notes, and we're talking close to a billion smackers here. It's a bold move to grease the wheels on looming acquisition maneuvers. We're looking at a €650 million and a £375 million stack of senior secured notes patiently...

Utility Switching for UK SMEs: More Than Just Price

Beyond the Price Tag: The Real Game of Utility Switching The grind for small and medium enterprises (SMEs) in the UK ain't just about finding the cheapest deals; it's about securing the right ones. Better Business Advice has highlighted Love Business for precisely this reason. They're helping companies navigate the complex web of commercial utility contracts—broadband,...

Seatrium, Karpowership Push Forward with Powership Deal

Seatrium Dives Deeper with Karpowership Here's a new chapter in the energy game, folks: Seatrium Limited and Karpowership are tightening their ties, sealing a deal to churn out these futuristic Whale Class Powerships. They're not just slapping some paint onto old relics; they're pioneering hydrogen-ready floating power plants that might just light up more than a few...

Electrolux Trends: Q3 '26 Shows Resilience Amid Challenges

Electrolux's Strategic Moves In A Tough Market Electrolux's Q3 2026 paints a gritty picture—yet there's a pulse of resilience underneath the numbers. Net sales bumped up to SEK 33,919m due to a 3.5% organic growth, showing the company's ability to swim through choppy waters. But let's not brush aside the sharp rocks they’re dodging: soaring raw materials and logistics...